2B Scientific adds business manager to support growth
2B Scientific has appointed Nihad Robinson as business manager.
Robinson joins the Upper Heyford, Oxfordshire firm from Cambridge Biosciences where she was responsible for technical sales in the South UK region. She has a degree in microbiology and a PhD in molecular biology, as well as being fluent in Arabic and French.
"I am very proud to be joining 2BScientific and look forward to helping develop the business," she said.
2B Scientific has also expanded its worldwide supplier network by signing deals with Spring Bioscience and BioDynamics.
"We are excited about our new partnerships with US-based Spring Bioscience and Japan's BioDynamics (Funakoshi)," said James Bernard, md of 2B Scientific. "Both of these companies have established businesses and the expertise that will help position the products successfully in the market."
2B Scientific has extended its catalogue portfolio to include Spring Bioscience's cancer markers and tumour suppressors, plus BioDynamic's Hetero-Stagger PCR Cloning Kit, which enables efficient and fast cloning of PCR products without needing any enzymatic procedures.
The firm also offers products from Acris Antibodies (Germany); Cosmo Bio (Japan); Symansis (New Zealand); and ExBio (Czech Republic), among others.
You may also like
Manufacturing
SCHOTT Pharma launches EVERIC lyo & amber vials for light-sensitive ADCs
Featuring the well-known EVERIC® lyo coating, EVERIC® lyo & amber is designed for lyophilised, light-sensitive antibody-drug-conjugates (ADCs). It offers reliable light protection at the primary packaging level, already during the fill-and-finish process. EVERIC amber is the first specialty vial for highly light-sensitive medications that simultaneously meets regulatory light transmission requirements in the EU, the U.S., and Japan
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Portable gas detection in the pharmaceutical sector
Gas safety is a critical consideration in the pharmaceutical sector. Hazardous gases and airborne contaminants are common by-products of manufacturing processes … and employers must control worker exposure in accordance with relevant legislation and industry standards
Manufacturing
New legal duties for QPs in decentralised manufacturing
In this clip, Dr. Peter Gough explains that QPs will be responsible for supervising decentralised activities, conducting regular audits, carrying out periodic on-site visits, confirming GMP compliance to regulatory authorities and notifying changes that may affect quality or safety
Manufacturing
FDA escalates action against Dabur India over systemic data-integrity and cGMP failures
The US FDA has issued a warning letter to Dabur India following an inspection that identified falsified records, missing laboratory data, inadequate cleaning and process validation and weaknesses in quality-unit oversight, saying the company's response failed to address the systemic nature of the deficiencies
Manufacturing
DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction
The pair will combine DNA Script's EDS technology with GE HealthCare's DNA scaling technology to create a faster, more flexible manufacturing process for cell-free DNA as the use of personalised and time-sensitive genetic medicines grows